Another take on the U's med-ethics policy


Not a world-class policy?

A bit after posting on some early reaction to the U’s new policy on conflicts of interest involving its medical school, I got this from U Professor Bill Gleason, who told me early on he didn’t think the U’s conflict-of-interest policy had any real bite.

He talks briefly to Pharmalot, which goes into more criticism of the policy and its controversial background.

They say the new policy lacks sanctions; there is no ban on consulting fees; there is no requirement for public disclosure of ties or holdings that may represent a conflict, and industry-funded continuing medical education is permitted, despite proposals to eliminate such financing.